Mexico’s Cannabis Gray Market: Legal Personal Use but No Commercial Framework in Sight

How can cannabis be legal in Mexico but still have no legal place to buy it?

The Mexico cannabis legalization status in 2026 is one of the most confusing regulatory situations in the Western Hemisphere: personal use is constitutionally protected, yet there is not a single licensed dispensary, retail store, or distribution point where any adult can legally purchase recreational cannabis anywhere in the country. Mexico decriminalized individual adult use in 2021 — and then stopped. What was supposed to be the first step in a comprehensive legalization process has instead become a permanent legal limbo, spawning one of the world’s most developed cannabis gray markets.

This post breaks down how Mexico arrived here, what the gray market actually looks like on the ground, why the commercial framework has stalled, and what this means for cannabis operators watching Latin America. For operators already navigating licensed markets, understanding where cannabis compliance software fits in a pre-framework environment is equally important.

Mexico Cannabis Legalization Status: Legal in Theory, Stalled in Practice

Understanding Mexico’s cannabis legalization status requires separating two distinct legal events that happened years apart — with nothing in between.

The first event came on October 31, 2018, when Mexico’s Supreme Court of Justice (SCJN) issued a jurisprudential thesis declaring the absolute prohibition on cannabis use unconstitutional under the constitutional right to free development of personality. This ruling did not automatically legalize cannabis — it ordered Congress to reform the General Health Law within 90 days. Congress missed that deadline, and several more after it.

The second event came on June 28, 2021, when the Supreme Court issued a General Declaration of Unconstitutionality — the strongest form of ruling in Mexican law — confirming that blanket prohibition on adult cannabis use violated constitutional rights. This created a formal administrative pathway: adults aged 18 and older could now apply to COFEPRIS (the Federal Commission for Protection Against Health Risks) for a sanitary authorization covering cultivation, harvesting, possession, and transportation of cannabis for personal use.

What Personal Use Authorization Actually Allows

The COFEPRIS authorization is narrowly scoped. It permits cultivation of up to 6 cannabis plants for personal use (8 plants for households with more than 2 adults), along with personal possession, transportation, sowing, harvesting, and preparation for personal consumption. It explicitly does not permit sale, commercialization, distribution, consumption in public spaces, or use around minors.

The process itself remains labyrinthine. Because COFEPRIS has not issued implementing guidelines as of mid-2025, the agency denies applications as a matter of course. The applicant must then file an amparo indirecto (constitutional injunction) in federal court, where a judge issues a sentence granting the permit. This indirect court route is the only working pathway — despite no legal barrier existing to a direct administrative approval. In practice, the vast majority of Mexican adults who consume cannabis do so without engaging this system at all, existing in a tolerance zone between constitutional protection and criminal exposure.

How the Gray Market Filled the Void

With personal use constitutionally protected but every commercial activity still illegal, Mexico’s cannabis gray market has evolved into a sophisticated parallel economy — most visibly in Mexico City, but spreading to Guadalajara, Monterrey, and tourist corridors across the country.

Gray market cannabis shops operate on a gift economy model: customers pay a membership fee or purchase a high-value item — a t-shirt, a subscription, a piece of art — and cannabis is provided as a complimentary “gift.” The transaction is transparent, the products are typically lab-tested for potency and contaminants, and the shops occupy storefronts in upscale urban neighborhoods. Mexico City’s Roma Norte, Condesa, and Colonia Juárez districts host multiple such establishments operating openly.

Mexico City’s government has responded pragmatically. Government-sanctioned tolerance zones were established and, ahead of the 2026 FIFA World Cup, relocated and formalized in August 2025. This creates a de facto regulatory layer — not legalization, but structured tolerance — that allows operators to function without constant fear of enforcement while providing the city with some degree of geographic control.

The market potential underlying this gray zone is enormous. Mexico’s recreational cannabis market is projected to grow at a 6.27% CAGR from 2024 to 2029, reaching a projected market volume of USD 3.05 billion — making it the second-largest recreational cannabis market in the Western Hemisphere by demand. Mexico also dominates the Latin America and Caribbean hemp-derived CBD market with a 29.5% revenue share as of 2024. None of this demand is being served by a licensed, regulated supply chain.

Legislative Obstacles and Political Gridlock

The gap between the Supreme Court’s constitutional mandate and congressional inaction is now seven years old. Understanding why Mexico’s commercial cannabis framework has not materialized requires examining structural, political, and bureaucratic obstacles simultaneously.

Missed deadlines. Congress was given 90 days after the 2018 Supreme Court ruling to reform the General Health Law. That deadline passed. Additional congressional sessions in 2019, 2020, and 2021 produced competing legislative proposals but no final vote. The 2021 declaration of unconstitutionality created renewed urgency — and produced another round of stalled bills.

Competing stakeholder interests. Legislative attempts have repeatedly foundered on the conflict between corporate stakeholders seeking a commercial licensing regime similar to Canada or U.S. state models, and social equity advocates demanding that Indigenous communities, small cultivators, and individuals incarcerated for cannabis offenses be centered in any legalization framework. Neither side has accepted a compromise bill.

The Sheinbaum administration. President Claudia Sheinbaum, who took office in October 2024, has not included cannabis legalization among her priority reforms. Her administration has publicly emphasized strict regulation of CBD products and enforcement of existing health standards. In March 2026, Sheinbaum suffered her first major legislative defeat — the failure of her electoral reform bill — demonstrating that her congressional coalition has limits, and that cannabis reform faces a long queue of higher-priority legislation.

COFEPRIS inaction. The regulatory agency has declined to issue implementing guidelines for the 2021 Supreme Court ruling even as the legal basis for doing so is clear. Applicants still must use the judicial amparo route because COFEPRIS has not taken the administrative steps the court anticipated. This bureaucratic paralysis has prevented even the personal use framework from functioning smoothly — let alone providing any pathway toward commercial activity.

What Mexico’s Cannabis Standstill Means for LATAM Operators

Mexico’s regulatory standstill has direct implications for any cannabis business with a Latin American strategy — whether operating in Mexico or building multi-country exposure across the region.

The gray zone carries real risk. Operating in Mexico’s gray market today means building without compliance infrastructure, without licensing protection, and without certainty about tomorrow’s enforcement environment. A single administration change, an unexpected Supreme Court action, or the sudden passage of commercial legislation could instantly alter the rules. Businesses in this environment face exposure that licensed operators in Colombia, Uruguay, or Brazil do not.

The opportunity is real — but the timing is uncertain. With USD 3 billion in projected demand and no legal supply chain, Mexico represents one of the largest untapped cannabis markets on Earth. When a commercial framework does arrive — through Congress, through executive regulatory action, or through continued judicial pressure — it will likely impose immediate compliance requirements: licensing conditions, seed-to-sale tracking, reporting standards. Operators who have built compliance infrastructure in advance will move faster than those starting from scratch on day one.

LATAM compliance complexity is increasing. Across Latin America, the regulatory environment is fragmenting: Brazil published four new ANVISA cultivation and manufacturing RDCs in early 2026; Colombia’s Decree 1138 opened pharmacy sales of medical cannabis flower; Argentina continues expanding its medicinal program. Mexico sits in a unique position — the largest economy in the region with the most demand and the least regulatory clarity. For operators building a multi-country LATAM strategy, the compliance burden is growing, not shrinking.

GrowerIQ’s cannabis compliance software is built for exactly this kind of evolving regulatory landscape — providing seed-to-sale traceability, digital record-keeping, and audit-ready documentation that can adapt as new frameworks emerge. Operators who invest in compliance infrastructure today will be positioned to activate quickly when Mexico’s commercial framework finally arrives.

Frequently Asked Questions

Navigating Latin America’s Emerging Markets?

GrowerIQ tracks regulatory changes across Latin America and helps operators stay compliant as frameworks evolve.

REQUEST DEMO